Oregon Health & Sciences University
Portland, Oregon, 97239, United States
NCT Number: NCT02256839
To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Portland, Oregon, 97239, United States
To compare the specificity of the CST001 assay to the QFT Gold Test in low TB exposure risk subjects and non-tuberculosis mycobacterial infections.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Low-exposure Risk Group
Inclusion criteria
Exclusion criteria
Non-tuberculous mycobacterial infection Group
Inclusion criteria
Exclusion criteria
Time frame: 1 day (At time of enrollment)
To compare the clinical specificity of the CST001 assay to the QuantiFERON-TB Gold test in low TB exposure risk subjects and non TB infected subjects based on an assessment of known risk factors. These subjects had no identified risk factors of TB infection.
QIAGEN Gaithersburg, Inc
Industry
Evaluation of the 4th Generation QuantiFERON-TB Gold Test (CST001) for the Detection of Tuberculosis Infection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06214910
Actinomycetales Infections, Bacterial Infections
Sweetwaters, KwaZulu-Natal, South Africa
View Trial DetailsNCT06739915
Acquired Immunodeficiency Syndrome, Actinomycetales Infections
Soweto, Gauteng, South Africa
View Trial DetailsNCT03896750
Actinomycetales Infections, Bacterial Infections
Miami, Florida, United States
View Trial DetailsNCT02906007
Actinomycetales Infections, Bacterial Infections
Port-au-Prince, Haiti
View Trial Details